Yahoo Web Search

  1. Ad
    related to Novartis Pharmaceuticals Corporation
  1. Yahoo Finance Results

  2. Landmark decisions last year include the approval of a couple of gene-based therapies for cancer – Novartis’s NVS Kymriah and Gilead Sciences’s GILD Yescarta. These therapies have the ...

  3. Stocks recently featured in the blog include Synergy Pharmaceuticals Inc. SGYP, Aradigm Corporation ARDM and Sucampo Pharmaceuticals, Inc. SCMP. Today, Zacks is promoting ...

  4. 5 of the Best-Performing Biotech Stocks of 2017

    Zacks via Yahoo FinanceDec 28 13:07 PM

    With just a few days left for the year to end, it can be said that 2017 turned out to be a pretty good year for the biotech sector. New product sales ramp up, R&D success and innovation, and ...

  5. 3 Best Healthcare Stocks of 2017

    Motley Fool via Yahoo FinanceJan 03 11:34 AM

    Madrigal Pharmaceuticals Madrigal Pharmaceuticals stock surged 516% in 2017, landing it the No. position among all healthcare stocks for the year. For Madrigal, success came in two phases.

  6. The drug is approved for several cancer indications including non-small cell lung cancer in combination with Eli Lilly's (LLY) Alimta and carboplatin. Price Merck & Company, Inc. Price | Merck & Company, Inc.

  7. The "Strategic Development of Neural Stem & Progenitor Cell Products (2018)" report has been added to Research and Markets' offering. During the development of the nervous system, neural progenitor ...

  8. Rocket’s Pipeline Rocket utilizes a multi-platform development approach that leverages the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene delivery methods ...

  9. Marijuana Stocks Set to Rebound After Comments from Sessions

    ACCESSWIRE via Yahoo FinanceJan 08 15:00 PM

    As many investors have seen this as a reason for supporting cannabis, several companies have begun to reach new investors, including GT Biopharma (GTBP) and ABcann Global (ABCCF). GT Biopharma ...

  10. Company: Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Type of Application: Supplemental New Drug Application, or sNDA Candidate: Trulance (plecanatide) Indication: Treating adults with ...

  11. How To Trade The JPMorgan Healthcare Conference

    Benzinga via Yahoo FinanceJan 08 18:19 PM

    Morgan Stanley expects a potential update on the companies cystic fibrosis triple-combination study would be the biggest possible conference catalyst. AveXis Inc (NASDAQ: AVXS) - Morgan Stanley ...

  1. Ads
    related to Novartis Pharmaceuticals Corporation